CHAD Therapeutics Names CFO Earl Yager to the Additional Post of President.Business Editors CHATSWORTH, Calif.--(BUSINESS WIRE)--Dec. 12, 2002 CHAD Therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. , Inc. (AMEX AMEX See: American Stock Exchange :CTU CTU Colorado Technical University CTU Czech Technical University in Prague CTU Counter Terrorist Unit CTU Clinical Trials Unit CTU Catholic Theological Union CTU Chicago Teachers Union CTU Computer Training Unit CTU Control Unit ), a producer and distributor of oxygen conserving devices and oxygen systems for pulmonary pulmonary /pul·mo·nary/ (pool´mo-nar?e) 1. pertaining to the lungs. 2. pertaining to the pulmonary artery. pul·mo·nar·y adj. Of, relating to, or affecting the lungs. patients who need supplementary oxygen, announced today that Earl L. Yager, currently Chief Operating Officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. and Chief Financial Officer, has been named to the additional post of President effective January 1, 2003. Thomas E. Jones, Chief Executive Officer, said, "I am pleased to announce this well-earned promotion and expansion of Earl's responsibilities at CHAD Therapeutics. Earl has been instrumental in the design and successful implementation of the strategic growth plan that is restoring CHAD's traditional leadership in the important conserver segment of the oxygen therapy market. Earl also has been responsible for spearheading our program to improve margins and reduce costs throughout the organization. These initiatives already have improved CHAD's operating performance, and we look for further revenue and earnings growth in the future. This promotion is a tangible sign of the Board's confidence in Earl's leadership, and recognizes his effectiveness in managing the company's day-to-day affairs." Mr. Yager, 56 years old, has been Chief Financial Officer of CHAD Therapeutics since 1983, a director since 1988, and Chief Operating Officer since 2000. Mr. Yager is a certified public accountant Certified Public Accountant (CPA) An accountant who has met certain standards, including experience, age, and licensing, and passed exams in a particular state. . About CHAD Therapeutics CHAD Therapeutics, Inc. is in the business of developing, producing and marketing respiratory care devices designed to improve the efficiency of oxygen delivery systems for home health care and hospital treatment of patients suffering from pulmonary diseases. For more information, visit www.CHADtherapeutics.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion